article thumbnail

COVID-19 Vaccine Safe for Children Who Had Previous MIS-C Diagnosis

Drug Topics

Patients with a history of multisystem inflammatory syndrome in children (MIS-C) completed a questionnaire about adverse reactions following COVID-19 vaccination, and no serious adverse events were recorded.

article thumbnail

How pharmacists can counsel patients on a bad reaction to a new medication

The Checkup by Singlecare

Nonimmunologic reactions. Nonimmunologic reactions are reactions that don’t involve the immune system and are not typically considered true allergic reactions. Instead, these non-allergic adverse reactions may be caused by the drug itself or unknown reasons. Most common culprits of reactions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Xdemvy side effects and how to avoid them

The Checkup by Singlecare

However, in the event of persistent or worsening Xdemvy side effects, it’s best to contact a healthcare provider. Adverse reactions As a new medication, most side effects of Xdemvy were observed in clinical trials under widely varying conditions. RELATED: How much does Xdemvy cost?

article thumbnail

Nivolumab approved in EU as adjuvant treatment for resected stage IIB or IIC melanoma 

Hospital Pharmacy Europe

In terms of safety, the pooled dataset of nivolumab as monotherapy found that some of the most frequent adverse reactions, occurring in more than 10% of patients, were fatigue (44%), musculoskeletal pain (28%), diarrhoea (26%), rash (24%) and cough (22%). This can be a very impactful event for patients.

article thumbnail

Nivolumab approved as adjuvant treatment for resected stage IIB or IIC melanoma 

Hospital Pharmacy Europe

In terms of safety, the pooled dataset of nivolumab as monotherapy found that some of the most frequent adverse reactions, occurring in more than 10% of patients, were fatigue (44%), musculoskeletal pain (28%), diarrhoea (26%), rash (24%), cough (22%). This can be a very impactful event for patients.

article thumbnail

FDA approves first treatment for geographic atrophy

European Pharmaceutical Review

A milestone for retinal ophthalmology The approval of SYFOVRE is the most important event in retinal ophthalmology in more than a decade.” It is a progressive and irreversible disease caused by the growth of lesions, which destroy the retinal cells responsible for vision.

FDA 87
article thumbnail

FDA approves first gene therapy for high-risk early bladder cancer

European Pharmaceutical Review

The failure to achieve a complete response (CR), or the disappearance of all signs of cancer as seen on cystoscopy, biopsied tissue, and urine, is associated with an increased risk of death or a disease-worsening event. Without treatment, the cancer can invade, damage tissues and organs, and spread through the body.

FDA 92